Novel Drug Approvals for 2026

FDA has determined that a REMS is no longer necessary to ensure ERA medicines’ benefits outweigh the risk of EFT.

Following a recall initiated by Fresh Creative Foods, a division of Reser’s Fine Foods, Inc., Albertsons Companies has voluntarily recalled select store-made deli items, supplied by Fresh Creative Foods, due to possible Listeria monocytogenes contamination. The recall was initiated because these pro

Antifungal Susceptibility Test Interpretive Criteria

Unapproved New Drugs/Misbranded

The U.S. Food and Drug Administration (FDA) is warning that cases of a rare but serious infection of the genitals and area around the genitals have been reported with the class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors.

CGMP/Finished Pharmaceuticals/Adulterated